Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Somatostatin Receptor Ligand. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 known ✓ | P31391 | 13/20 | 0.81 |
| ▸ | SSTR5 known ✓ | P35346 | 11/20 | 0.81 |
| ▸ | SSTR2 known ✓ | P30874 | 10/20 | 0.81 |
| ▸ | SSTR1 known ✓ | P30872 | 10/20 | 0.81 |
| ▸ | SSTR3 known ✓ | P32745 | 10/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Somatostatin Receptor Ligand SCHEMBL5698935 | 0.99 | SSTR4 (0.80) | SSTR4SSTR5SSTR2SSTR1SSTR3 | |
| Somatostatin SCHEMBL29350200 | 0.99 | SSTR4 (0.83) | SSTR4SSTR5SSTR2SSTR1SSTR3 | |
| Somatostatin Receptor Ligand SCHEMBL8482 | 0.99 | SSTR4 (0.83) | SSTR4SSTR5SSTR2SSTR1SSTR3 | |
| Somatostatin Receptor Ligand SCHEMBL29386529 | 0.99 | SSTR4 (0.83) | SSTR4SSTR5SSTR2SSTR1SSTR3 | |
| Somatostatin Receptor Ligand SCHEMBL3046327 | 0.99 | SSTR4 (0.83) | SSTR4SSTR5SSTR2SSTR1SSTR3 | |
| Somatostatin Receptor Ligand SCHEMBL31432768 | 0.99 | SSTR4 (0.83) | SSTR4SSTR5SSTR2SSTR1SSTR3 | |
| Somatostatin Receptor Ligand SCHEMBL16062971 | 0.99 | SSTR4 (0.83) | SSTR4SSTR5SSTR2SSTR1SSTR3 | |
| Somatostatin Receptor Ligand SCHEMBL12548326 | 0.99 | SSTR4 (0.83) | SSTR4SSTR5SSTR2SSTR1SSTR3 | |
| Somatostatin SCHEMBL21361053 | 0.99 | SSTR4 (0.83) | SSTR4SSTR5SSTR2SSTR1SSTR3 | |
| SCHEMBL29368491 | 0.99 | SSTR4 (0.83) | SSTR4SSTR5SSTR2SSTR1SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115192542-B | Oral nanometer drug delivery system mediated by small molecule nutrient substances | 四川大学 | 2023-09-08 | — | — | CN | claimed |
| CN-115192542-A | Oral nano drug delivery system mediated by small molecular nutrient substances | 四川大学 | 2022-10-18 | — | — | CN | claimed |
| CN-115040495-A | Oral nano drug delivery system mediated by small molecular nutrient substances | 四川大学 | 2022-09-13 | — | — | CN | claimed |
| CN-112755005-B | Oral nano drug delivery system mediated by small molecular nutrient substances | 四川大学 | 2022-05-13 | — | — | CN | claimed |
| CN-111303473-B | Preparation method of powder injection rubber plug | 北京市新里程医药科技有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-112755005-A | Oral nano drug delivery system mediated by small molecular nutrient substances | 四川大学 | 2021-05-07 | — | — | CN | claimed |
| US-20210106538-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2021-04-15 | — | — | US | claimed |
| CN-112641757-A | Carrier for transmembrane delivery of molecules and preparation method thereof | 中国药科大学 | 2021-04-13 | — | — | CN | claimed |
| CN-111471206-A | Preparation method of rubber plug for powder injection of somatostatin and derivatives thereof | 北京市新里程医药科技有限公司 | 2020-07-31 | — | — | CN | claimed |
| CN-111303473-A | Preparation method of powder injection rubber plug | 北京市新里程医药科技有限公司 | 2020-06-19 | — | — | CN | claimed |
| EP-3471778-A2 | COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS | The Regents of The University of Michigan (US) | 2019-04-24 | — | — | EP | claimed |
| CN-105412935-B | One kind being based on the nanoparticle and preparation method thereof of N- (2- hydroxypropyl) methacrylamide polymer | 四川大学 | 2019-02-19 | — | — | CN | claimed |
| WO-2018156617-A2 | COMPOSITIONS AND METHODS FOR DELIVERY OF POLYMER / BIOMACROMOLECULE CONJUGATES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2018-08-30 | — | — | WO | claimed |
| WO-2017223085-A2 | COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2017-12-28 | — | — | WO | claimed |
| US-20110124563-A1 | PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF SOMATOSTATIN OR AN ANALOGUE THEREOF | GP PHARM S.A. | 2011-05-26 | — | — | US | claimed |
| EP-2223684-A2 | PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF SOMATOSTATIN OR AN ANALOGUE THEREOF | GP Pharm S.A. (ES) | 2010-09-01 | — | — | EP | claimed |
| CN-1508152-A | Somatostatin full-synthesis method | 常州市第四制药厂有限公司 | 2004-06-30 | — | — | CN | claimed |
| US-4835138-A | Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities | MERCK & CO., INC. (US) | 1989-05-30 | — | — | US | claimed |
| US-12622922-B2 | Compositions and methods for metal containing formulations capable of modulating immune response | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2026-05-12 | — | — | US | disclosed |
| CN-1508152-A | Somatostatin full-synthesis method | 常州市第四制药厂有限公司 | 2004-06-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622922-B2 | Compositions and methods for metal containing formulations capable of modulating immune response | STING1, CGAS, TLR3 | SSTR4 3263/4885SSTR5 3634/4885SSTR2 2182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.